326 related articles for article (PubMed ID: 8756624)
1. Cyclin-binding motifs are essential for the function of p21CIP1.
Chen J; Saha P; Kornbluth S; Dynlacht BD; Dutta A
Mol Cell Biol; 1996 Sep; 16(9):4673-82. PubMed ID: 8756624
[TBL] [Abstract][Full Text] [Related]
2. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
3. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.
Saha P; Eichbaum Q; Silberman ED; Mayer BJ; Dutta A
Mol Cell Biol; 1997 Aug; 17(8):4338-45. PubMed ID: 9234691
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
[TBL] [Abstract][Full Text] [Related]
6. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
7. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
Adams PD; Sellers WR; Sharma SK; Wu AD; Nalin CM; Kaelin WG
Mol Cell Biol; 1996 Dec; 16(12):6623-33. PubMed ID: 8943316
[TBL] [Abstract][Full Text] [Related]
8. The amino terminus of Cdk2 binds p21.
Moskowitz NK; Borao FJ; Dardashti O; Cohen HD; Germino FJ
Oncol Res; 1996; 8(9):343-52. PubMed ID: 8979268
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
10. The association of cyclin A and cyclin kinase inhibitor p21 in response to gamma-irradiation requires the CDK2 binding region, but not the Cy motif.
Fukuchi K; Nakamura K; Ichimura S; Tatsumi K; Gomi K
Biochim Biophys Acta; 2003 Oct; 1642(3):163-71. PubMed ID: 14572899
[TBL] [Abstract][Full Text] [Related]
11. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
12. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
Hengst L; Göpfert U; Lashuel HA; Reed SI
Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
[TBL] [Abstract][Full Text] [Related]
13. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
Ding QM; Ko TC; Evers BM
Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
16. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
Chen J; Jackson PK; Kirschner MW; Dutta A
Nature; 1995 Mar; 374(6520):386-8. PubMed ID: 7885482
[TBL] [Abstract][Full Text] [Related]
17. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Harper JW; Adami GR; Wei N; Keyomarsi K; Elledge SJ
Cell; 1993 Nov; 75(4):805-16. PubMed ID: 8242751
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
19. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
20. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
